Catecholamines and neurologic diseases (first of two parts).
D000818:Animals; D001921:Brain / Q000201:enzymology / Q000378:metabolism*; D002395:Catecholamines / Q000096:biosynthesis / Q000134:cerebrospinal fluid / Q000378:metabolism*; D002555:Cerebrospinal Fluid / Q000378:metabolism; D004195:Disease Models, Animal; D006719:Homovanillic Acid / Q000652:urine; D006801:Humans; D009411:Nerve Endings; D009422:Nervous System Diseases / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology; D009474:Neurons / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D013569:Synapses / Q000187:drug effects / Q000502:physiology; D009435:Synaptic Transmission / Q000187:drug effects
D002395:Catecholamines; D006719:Homovanillic Acid